NCT03090971View on ClinicalTrials.gov

Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

March 23, 2017

Study Completion Date

June 30, 2017

Conditions
Neurofibromatosis 1Cutaneous Neurofibroma
Interventions
DRUG

Diclofenac Sodium

Following microporation, treatment neurofibromas will receive treatment with topical diclofenac

DRUG

Saline Solution

Following microporation, control neurofibromas will receive treatment with topical saline

Trial Locations (1)

25964-000

Fundação Educacional Serra dos Órgãos - UNIFESO, Teresópolis

All Listed Sponsors
lead

Fundação Educacional Serra dos Órgãos

OTHER

NCT03090971 - Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1 | Biotech Hunter | Biotech Hunter